Encompass Health Corporation
Business Overview: Encompass Health Corporation (NYSE: EHC)
Executive Summary
Encompass Health Corporation is the nation's largest owner and operator of inpatient rehabilitation hospitals by patients treated, revenue, and hospital count, operating 173 hospitals across 39 states and Puerto Rico as of December 31, 2025, with 11,465 licensed beds and significant concentrations in Florida and Texas. The company owns approximately 79% of its hospital real estate, treated 263,299 patient discharges in 2025, and generated $5.94 billion in total net operating revenues — a business almost entirely dependent on Medicare and Medicare Advantage, which together represent 81.8% of total revenue.
1. Core Business Model & How They Work
Encompass Health provides specialized, intensive inpatient rehabilitative care to patients recovering from major injuries or illnesses — stroke, traumatic brain injury, spinal cord injury, major orthopedic surgery, and similar conditions — with the goal of restoring functional ability and independence before discharge.
[ Acute-Care Hospital Referrals (~92% of admissions) ] -> [ Encompass Health Inpatient Rehabilitation Hospitals: 173 Facilities, 11,465 Beds ] -> [ Intensive Therapy + Medical Care ] -> [ Discharge to Home/Community ]The near-total reliance on physician referrals from acute-care hospitals (92% of admissions) makes referral relationships and clinical outcome reputation central to the business — hospitals and physicians need confidence that patients will receive high-quality rehabilitative care to justify the referral and discharge planning effort.
2. Business Segments
Encompass Health operates as a single-focus business — inpatient rehabilitation — but differentiates through clinical specialization: 148 of its 173 hospitals hold stroke certifications, reflecting a deliberate strategic emphasis on stroke rehabilitation as a growth and quality differentiator. The company's payer mix underscores its structural dependence on government healthcare programs: Medicare (65.4% of revenue), Medicare Advantage (16.4%), and Medicaid (just 3.1%) — with an average Medicare patient age of approximately 77.
3. Product Portfolio
Encompass Health's "product" is specialized inpatient rehabilitative care itself, differentiated by clinical outcomes, facility quality, and certifications (particularly stroke certification across 148 of 173 hospitals). The company's real estate ownership (79% of hospital properties) is itself a strategic asset, providing balance-sheet stability and reducing exposure to lease-cost inflation relative to competitors that lease most of their facilities.
4. Competitive Landscape
Encompass Health competes against rehabilitation units embedded within acute-care hospitals, privately held rehabilitation service providers, one other public company operating 38 inpatient rehabilitation hospitals, and nursing homes offering more limited rehabilitation services. The company's scale (173 hospitals versus a next-largest public competitor's 38) is itself a significant competitive advantage, supporting national referral relationships, cost efficiencies, and the capital base needed for continued hospital development and technology investment.
5. Strategic Strengths & Risks
Strengths:
- Dominant scale as the largest inpatient rehabilitation hospital operator in the U.S., roughly 4.5x the hospital count of its largest named public competitor.
- Ownership of approximately 79% of hospital real estate provides balance sheet stability and insulation from lease cost inflation.
- Strong clinical differentiation through stroke certification at 148 of 173 hospitals, supporting referral relationships in a high-value rehabilitation category.
- "Strong, well-capitalized balance sheet" with no significant debt maturities until 2028, providing financial flexibility for continued hospital development.
- Established referral relationships with acute-care health systems, including joint ventures that deepen institutional ties.
Risks:
- Extreme payer concentration: Medicare and Medicare Advantage together represent 81.8% of revenue, making the company acutely sensitive to any federal reimbursement rate changes or policy shifts.
- Complex regulatory compliance burden, including the "60% Rule" (minimum patient population from 13 specified medical conditions required to maintain inpatient rehabilitation facility classification), False Claims Act, Anti-Kickback Law, and Stark Law exposure.
- Approximately 36% of licensed beds operate in states with Certificate of Need requirements, which can constrain capacity expansion in those markets.
- Workforce retention challenges: full-time nurse turnover of 20.2% in 2025 reflects broader healthcare labor market pressures.
- Geographic concentration in Florida and Texas creates regional regulatory and demographic exposure.
- Staffing shortages and continued pandemic-related disruption risk are explicitly flagged as material business risks.
6. Financial Overview
Fiscal year 2025: total net operating revenues of $5.94 billion (inpatient revenues of $5.76 billion), 263,299 discharges, and a payer mix of 65.4% Medicare, 16.4% Medicare Advantage, and 3.1% Medicaid. The company employed over 42,000 people (24,611 full-time, 3,322 part-time, 14,367 pool/per diem) as of December 31, 2025, with minimal union representation (50 employees at a single facility). The balance sheet carries no significant debt maturities until 2028.
7. Summary Conclusion
Encompass Health has built genuine, durable scale advantages as the dominant player in U.S. inpatient rehabilitation — a fragmented category where its next-largest public competitor operates less than a quarter as many hospitals — reinforced by majority real estate ownership and deep stroke-care clinical specialization. The business's defining structural risk is its near-total dependence on Medicare and Medicare Advantage reimbursement (81.8% of revenue combined), making federal healthcare policy and reimbursement rate decisions the single most important external variable for the company's long-term economics, alongside ongoing clinical workforce retention pressure industry-wide.